abstract |
The invention relates to compounds of formula (I): n nor a salt thereof, wherein R 1 , R 5 , R 7 , R 8 , X, m, n, p and q are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating tissue specific fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). |